ESR1 and breast carcinoma: Approximately 70% breast cancer patient express estrogen receptor (ER) according to American Cancer Society [1], adjuvant endocrine therapy is the routine regimen, and only for ER-positive patients with high HG, combined chemotherapy is suggested.